CCL2 and chronic kidney disease: Indeed, the uraemic toxin indoxyl sulphate confers an additional cardiovascular risk in CKD and upregulates the expression of intercellular adhesion molecule-1 (ICAM) and monocyte chemotactic protein-1 (MCP-1) [25].